US equities
|
SPCX
$147.79
▲+0.00%
MU
$896.07
▲+0.00%
TSLA
$373.71
▲+0.00%
NVDA
$216.47
▲+0.00%
SNDK
$1,365.38
▲+0.00%
SKHY
$139.79
▲+0.00%
INTC
$91.69
▲+0.00%
AMD
$534.74
▲+0.00%
SPCX
$147.79
▲+0.00%
MU
$896.07
▲+0.00%
TSLA
$373.71
▲+0.00%
NVDA
$216.47
▲+0.00%
SNDK
$1,365.38
▲+0.00%
SKHY
$139.79
▲+0.00%
INTC
$91.69
▲+0.00%
AMD
$534.74
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about JP:4901
Recent news which mentions JP:4901
The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
October 14, 2021
Tickers
APLIF
AVIR
MRK
PFE
Tags
AVIR
JP:4901
CH:ROG
From
MarketWatch